Publicacións nas que colabora con María Luisa Laorden Carrasco (22)

2019

  1. Modulation of stress- and cocaine prime-induced reinstatement of conditioned place preference after memory extinction through dopamine D3 receptor

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 92, pp. 308-320

  2. Pharmacological modulation of the behavioral effects of social defeat in memory and learning in male mice

    Psychopharmacology, Vol. 236, Núm. 9, pp. 2797-2810

2018

  1. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 84, pp. 102-114

2017

  1. Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories

    Molecular Neurobiology, Vol. 54, Núm. 8, pp. 6523-6541

  2. Repeated social defeat and the rewarding effects of cocaine in adult and adolescent mice: dopamine transcription factors, proBDNF signaling pathways, and the TrkB receptor in the mesolimbic system

    Psychopharmacology, Vol. 234, Núm. 13, pp. 2063-2075

2016

  1. Different contribution of glucocorticoids in the basolateral amygdala to the formation and expression of opiate withdrawal-associated memories

    Psychoneuroendocrinology, Vol. 74, pp. 350-362

  2. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal

    Addiction Biology, Vol. 21, Núm. 2, pp. 374-386

2015

  1. Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference

    Neuropharmacology, Vol. 95, pp. 168-180

  2. Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal

    Brain Structure and Function, Vol. 220, Núm. 4, pp. 1901-1919

  3. Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons

    Addiction Biology, Vol. 20, Núm. 1, pp. 104-119

2013

  1. Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function

    British Journal of Pharmacology, Vol. 168, Núm. 8, pp. 1889-1901

2012

  1. Glucocorticoids Regulation of FosB/ΔFosB Expression Induced by Chronic Opiate Exposure in the Brain Stress System

    PLoS ONE, Vol. 7, Núm. 11

  2. Hypothalamic orexin-A neurons are involved in the response of the brain stress system to morphine withdrawal

    PLoS ONE, Vol. 7, Núm. 5

  3. Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal

    PLoS ONE, Vol. 7, Núm. 2

2011

  1. CRF 2 mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats

    British Journal of Pharmacology, Vol. 162, Núm. 4, pp. 851-862

2010

  1. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal

    Molecular Pharmacology, Vol. 77, Núm. 5, pp. 864-873

2009

  1. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus

    European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 1-8

  2. Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal

    Endocrinology, Vol. 150, Núm. 7, pp. 3118-3127

2008

  1. Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Núm. 4, pp. 407-420

2007

  1. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal

    Journal of Neurochemistry, Vol. 101, Núm. 4, pp. 1060-1071